Contribution of the transperineal prostatic biopsy: descriptive study of the first cases at the Hôpital Général Idrissa Pouye, Dakar

\r\nIntroduction:\r\nProstate cancer is one of the most common malignancies among men aged over 50 years and the leading cause of cancer-related death in men after lung cancer. Diagnosis is done by transrectal or transperineal prostate biopsy with ultrasound guidance. While transrectal biopsy exposes the patient to infectious risk, a transperineal biopsy is an innovative technique with the advantage of limiting these risks and offering better anterior prostate sampling. It is replacing transrectal biopsy, known as the gold standard for prostate cancer diagnosis. Our study aims to describe the practice of transperineal prostate biopsy at Hôpital Général Idrissa Pouye (HOGIP), evaluate morbidity, and present the results.\r\n\r\nMaterials and methods:\r\nWe conducted a descriptive, single-centre and cross-sectional study of patients who underwent a transperineal prostate biopsy at the urology department of HOGIP. We collected epidemiological, clinical, and paraclinical data. Analysis was done in Epi Info 7.2.5.0, and statistical significance was considered for α = 0.05 and, therefore, a p-value